Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alisporivir with peginterferon alfa-2a and ribavirin in prior protease inhibitor failure hepatitis C genotype 1
2011-004653-31Phase 3Terminated
- Sponsor
- Novartis
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of alisporivir in chronic hepatitis C virus infection, sponsored by Novartis. Primary endpoint: SVR12 LOQ. Started Dec 2011; status: terminated.
02
Drugs
alisporivir
03
Conditions
chronic hepatitis C virus infection
Beyond the preview
Go deeper on 2011-004653-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004653-31.